CVR 56759514Public limited company (A/S)Fremstilling af farmaceutiske præparater (212000)Secondary industries: Engroshandel med medicinalvarer og sygeplejeartikler (464610), Fremstilling af farmaceutiske råvarer (211000)BallerupFounded 10 Feb 1962
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about LEO PHARMA A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
1,060
CVR, Aug 2026
+21 (+2%) over 12 months
Revenue
13.5B
DKK, group, annual report 2025
+8.4% on 2024
Result
+2.5B
DKK, group, annual report 2025
Equity
5.3B
DKK, group, annual report 2025
LEO Holding A/SCVR 39122251, 66.7% to under 90% of capital, 90% to under 100% of votes
Cidron Savanna 4 SARL15% to under 20% of capital
Operating company
Dandex estimate: 1,060 employees registered in 2026Philip Harald Eickhoffsince 15 Sep 2022
Christophe Dominique Luc Charles Bourdonsince 1 Apr 2022
Owners of 5% or more. CVR registers shares in bands, not exact figures.
CVR 3912225166.7% to under 90% of capital, 90% to under 100% of votesclass A+Bnotified 21 Jul 2021since 30 Nov 2017
15% to under 20% of capitalclass Bnotified 20 Sep 2023since 21 Jul 2021
CVR 11623336100% of capital and votesclass A+Bnotified 30 Nov 201719 Apr 1993 to 30 Nov 2017
Ultimate controller
CVR 11623336Commercial foundation (erhvervsdrivende fond)
Holding in LEO Holding A/S, since 29 Nov 2017
Holding company
CVR 39122251Public limited company (A/S)
Holding in LEO PHARMA A/S, since 30 Nov 2017
This company
LEO PHARMA A/S
CVR 56759514
1 Danish company.
SubsidiaryCVR 24238113100% of capital and votes
Danish companies held at 5% or more, from the CVR owner register (ejerregister), and their holdings one level down. Foreign holdings are not in CVR. Subsidiary (datterselskab): 50% or more of the votes, a Dandex estimate; in the 50% band a joint venture is not ruled out.
CVR 41600004100% of capital and votes13 Aug 2020 to 23 May 2023
CVR 41600020100% of capital and votes13 Aug 2020 to 2 May 2022
CVR 41600039100% of capital and votes13 Aug 2020 to 31 Jan 2022
CVR 39128012100% of capital and votes30 Nov 2017 to 20 Dec 2018
CVR 27159133100% of capital and votes17 Sep 2012 to 27 Nov 2017
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Showing 50 of 75 former officers.
Showing 25 of 75. The list above has every one.
Aug 2026, monthly: 1,060 employees, 997 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | Q1 2010 | Q2 2010 | Q3 2010 | Q4 2010 | 2011 | 2012 | 2013 | 2014 | Jan 2015 | Feb 2015 | Mar 2015 | Apr 2015 | May 2015 | Jun 2015 | Jul 2015 | Aug 2015 | Sep 2015 | Oct 2015 | Nov 2015 | Dec 2015 | Jan 2016 | Feb 2016 | Mar 2016 | Apr 2016 | May 2016 | Jun 2016 | Jul 2016 | Aug 2016 | Sep 2016 | Oct 2016 | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 1,436 | 1,386 | 1,365 | 1,265 | 1,277 | 1,256 | 1,266 | 1,238 | 1,225 | 1,229 | 1,206 | 1,216 | 1,228 | No count | No count | No count | No count | 1,446 | 1,480 | 1,542 | 1,573 | 1,628 | 1,638 | 1,644 | 1,685 | 1,705 | 1,719 | 1,711 | 1,734 | 1,756 | 1,767 | 1,797 | 1,809 | 1,837 | 1,867 | 1,883 | 1,902 | 1,927 | 1,910 | 1,912 | 1,914 | 1,920 | 1,919 | 1,927 | 1,951 | 1,957 | 1,968 | 1,965 | 1,962 | 1,975 | 1,976 | 1,985 | 1,932 | 1,988 | 2,034 | 2,026 | 2,003 | 2,024 | 2,045 | 2,035 | 2,053 | 2,065 | 2,084 | 2,065 | 2,081 | 2,092 | 2,100 | 2,116 | 2,126 | 2,143 | 2,130 | 2,146 | 2,213 | 2,224 | 2,249 | 2,253 | 2,263 | 2,281 | 2,331 | 2,358 | 2,308 | 2,298 | 2,304 | 2,311 | 2,410 | 2,318 | 2,318 | 2,286 | 2,276 | 2,249 | 2,153 | 2,128 | 2,131 | 2,103 | 2,081 | 2,055 | 2,171 | 2,019 | 2,024 | 1,993 | 1,985 | 1,970 | 1,956 | 1,943 | 1,946 | 1,920 | 1,888 | 1,872 | 2,070 | 1,813 | 1,807 | 1,796 | 1,726 | 1,714 | 1,706 | 1,686 | 1,707 | 1,642 | 1,621 | 1,587 | 1,832 | 1,492 | 1,445 | 1,408 | 1,310 | 1,294 | 1,291 | 1,287 | 1,276 | 1,263 | 1,264 | 1,256 | 1,800 | 1,232 | 1,223 | 1,214 | 1,192 | 1,169 | 1,142 | 1,132 | 1,128 | 1,112 | 1,101 | 1,073 | 1,393 | 1,055 | 1,054 | 1,038 | 1,039 | 1,046 | 1,031 | 1,035 | 1,054 | 1,047 | 1,059 | 1,070 | 1,307 | 1,063 | 1,061 | 1,047 | 1,060 |
| FTE | 1,327 | 1,359 | 1,345 | 1,230 | 1,226 | 1,238 | 1,237 | 1,229 | 1,153 | 1,182 | 1,146 | 1,167 | 1,214 | 1,300 | 1,364 | 1,374 | 1,445 | 1,482 | 1,523 | 1,516 | 1,515 | 1,528 | 1,545 | 1,554 | 1,589 | 1,605 | 1,617 | 1,594 | 1,606 | 1,662 | 1,676 | 1,700 | 1,710 | 1,731 | 1,759 | 1,770 | 1,790 | 1,811 | 1,798 | 1,780 | 1,752 | 1,799 | 1,808 | 1,813 | 1,836 | 1,828 | 1,850 | 1,839 | 1,846 | 1,856 | 1,866 | 1,869 | 1,827 | 1,866 | 1,914 | 1,903 | 1,900 | 1,905 | 1,932 | 1,919 | 1,939 | 1,938 | 1,973 | 1,952 | 1,956 | 1,985 | 2,000 | 2,007 | 2,023 | 2,019 | 2,003 | 2,014 | 2,076 | 2,074 | 2,121 | 2,112 | 2,100 | 2,156 | 2,187 | 2,228 | 2,149 | 2,143 | 2,181 | 2,165 | 2,296 | 2,213 | 2,201 | 2,154 | 2,138 | 2,094 | 2,043 | 2,034 | 2,045 | 2,023 | 1,992 | 1,946 | 2,082 | 1,938 | 1,921 | 1,897 | 1,860 | 1,876 | 1,880 | 1,850 | 1,867 | 1,826 | 1,804 | 1,769 | 1,959 | 1,700 | 1,720 | 1,688 | 1,621 | 1,630 | 1,637 | 1,593 | 1,600 | 1,537 | 1,546 | 1,504 | 1,770 | 1,441 | 1,380 | 1,336 | 1,217 | 1,240 | 1,232 | 1,233 | 1,247 | 1,204 | 1,210 | 1,215 | 1,410 | 1,180 | 1,176 | 1,146 | 1,114 | 1,109 | 1,080 | 1,079 | 1,091 | 1,045 | 1,031 | 1,015 | 1,202 | 1,002 | 1,011 | 983 | 976 | 992 | 977 | 991 | 1,020 | 1,001 | 1,014 | 1,016 | 1,127 | 1,018 | 1,014 | 996 | 997 |
| Series | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Quarterly | Quarterly | Quarterly | Quarterly | Annual | Annual | Annual | Annual | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group. CVR changed its monthly method in Oct 2019: a step there need not be real.
Source: CVR, latest Aug 2026, published 22 Oct 2026.
Group figures (koncern), each year in its report's currency, from the annual reports filed in XBRL.
| Thousands | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 9,957,000 | 10,641,000 | 11,392,000 | 12,453,000 | 13,499,000 |
| Gross profit | 5,995,000 | 5,985,000 | 7,111,000 | 7,518,000 | 8,240,000 |
| Operating profit | -4,156,000 | -3,311,000 | -1,699,000 | -1,143,000 | +2,279,000 |
| Result for the year | -4,868,000 | -4,110,000 | -3,607,000 | -1,776,000 | +2,489,000 |
| Equity | 5,537,000 | 1,946,000 | 4,525,000 | 2,704,000 | 5,262,000 |
| Total assets | 23,695,000 | 22,932,000 | 20,951,000 | 20,151,000 | 20,445,000 |
| Credit metrics (Dandex calculations) | |||||
| Revenue growth (omsætningsvækst) | -1.7% | 6.9% | 7.1% | 9.3% | 8.4% |
| EBIT margin (overskudsgrad) | -41.7% | -31.1% | -14.9% | -9.2% | 16.9% |
| EBITDA | Not reportednote 1 | -1,574,000 | 551,000 | 599,000 | 3,751,000 |
| EBITDA margin (EBITDA-margin) | Not reportednote 1 | -14.8% | 4.8% | 4.8% | 27.8% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | 1,350,000 | 1,495,000 | 556,000 | 320,000 | 1,126,000 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions.
Large listed filers report IFRS figures in an ESEF report, for the group where there is one.
How each credit metric is calculated:
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for LEO PHARMA A/S:
Have Pro? Sign in.
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move. Implied value is the whole capital after the step at its cash price, not a valuation.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseBonus issue from reserves | None | None | None | 383,582,682 | |
| IncreaseCashPaid in 6,844,233, cash price 101.36, implied value 38,854,224,906 | 101.36 | 6,844,233 | 38,854,224,906 | 383,328,975 | |
| IncreaseCashPaid in 7,002,050, cash price 101.36, implied value 38,847,380,673 | 101.36 | 7,002,050 | 38,847,380,673 | 383,261,451 | |
| IncreaseCashPaid in 7,452,697, cash price 101.36, implied value 38,840,378,623 | 101.36 | 7,452,697 | 38,840,378,623 | 383,192,370 | |
| IncreaseCashPaid in 7,597,540, cash price 101.36, implied value 38,832,925,926 | 101.36 | 7,597,540 | 38,832,925,926 | 383,118,843 | |
| IncreaseDebt conversion, cashPaid in 6,300,324,339, cash price 101.36, implied value 38,825,328,386 | 101.36 | 6,300,324,339 | 38,825,328,386 | 383,043,887 | |
| IncreaseCashPaid in 7,390,778, cash price 47.72, implied value 15,312,679,491 | 47.72 | 7,390,778 | 15,312,679,491 | 320,885,991 | |
| IncreaseCashPaid in 8,546,509, cash price 47.72, implied value 15,305,288,712 | 47.72 | 8,546,509 | 15,305,288,712 | 320,731,113 |
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseCashPaid in 9,143,009, cash price 47.72, implied value 15,296,742,204 | 47.72 | 9,143,009 | 15,296,742,204 | 320,552,016 | |
| IncreaseCashPaid in 10,276,407, cash price 47.72, implied value 15,287,599,195 | 47.72 | 10,276,407 | 15,287,599,195 | 320,360,419 | |
| IncreaseCashPaid in 3,347,147,425, cash price 47.72, implied value 15,276,522,425 | 47.72 | 3,347,147,425 | 15,276,522,425 | 320,145,071 | |
| IncreaseCashPaid in 115,000,000, cash price 1.15, implied value 287,500,000 | 1.15 | 115,000,000 | 287,500,000 | 250,000,000 | |
| IncreaseCashPaid in 50,000,000 | None | 50,000,000 | None | 150,000,000 | |
| IncreaseBonus issue from reserves | None | None | None | 100,000,000 | |
| FoundingNot read from the announcement | None | None | None | 20,000,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Merger (fusion), as the continuing company (fortsættende selskab)
Source: CVR, read 17 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 17 Nov 2026.
The newest 50 of 121 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Bestyrelse:
Valgt af medarbejderne i virksomheden:
Suppleanter for valgt af medarbejderne i virksomheden:
Fratrådte:
Karen Louise Lauesen, den 01.11.2026.
Tiltrådte:
Sebastian Becker Adriansen, den 01.11.2026.
Vedtægter ændret: 25.02.2026
Bestyrelse:
Fratrådte:
Lars Green, den 25.02.2026, Peter Helt Jacobsen Haahr, den 25.02.2026.
Tiltrådte:
Kasper Fangel, den 25.02.2026, Peter Helt Jacobsen Haahr, (næstformand), den 25.02.2026.
Valgt af medarbejderne i virksomheden:
Fratrådte:
Henrik Bo Andersson, den 25.02.2026, Jannie Kogsbøll, den 25.02.2026.
Tiltrådte:
Allan Carsten Dahl, den 25.02.2026, Thomas Christian Facius, den 25.02.2026.
Suppleanter for valgt af medarbejderne i virksomheden:
Fratrådte:
Thomas Christian Facius, den 25.02.2026, Poul Bo Kilund, den 25.02.2026, Klaus Legau, den 25.02.2026, Rifat Ramicevic, den 25.02.2026.
Tiltrådte:
Henrik Bo Andersson, den 25.02.2026, Christina Dahl, den 25.02.2026, Karen Louise Lauesen, den 25.02.2026, Thomas Christian Vaarby, den 25.02.2026.
Selskabet tegnes af formanden og en næstformand i forening, formanden i forening med et bestyrelsesmedlem, formanden i forening med den administrerende direktør, en næstformand i forening med den administrerende direktør, den administrerende direktør i forening med et bestyrelsesmedlem, to bestyrelsesmedlemmer i forening med en direktør, to direktører i forening, eller den samlede bestyrelse i forening.
Bestyrelse:
Valgt af medarbejderne i virksomheden:
Suppleanter for valgt af medarbejderne i virksomheden:
Fratrådte:
Kreesten Meldgaard Madsen, den 27.06.2025.
Tiltrådte:
Rifat Ramicevic, den 27.06.2025.
Bestyrelse:
Valgt af medarbejderne i virksomheden:
Suppleanter for valgt af medarbejderne i virksomheden:
Fratrådte:
Sara Melissa Plov Hoff, den 13.03.2025.
Tiltrådte:
Poul Bo Kilund, den 13.03.2025.
Vedtægter ændret: 25.02.2025
Vedtægter ændret: 01.01.2025
Kapitalforhøjelsen er besluttet den 01.01.2025.
kr. 253.707,00, indbetalt ved overførte reserver / overskud, kurs 100,00.
Kapitalen udgør herefter kr. 383.582.682,00.
Vedtægter ændret: 31.12.2024
Kapitalforhøjelsen er besluttet den 31.12.2024.
kr. 67.524,00, indbetalt kontant, kurs 10.136,00.
Kapitalen udgør herefter kr. 383.328.975,00.
Vedtægter ændret: 04.12.2024
Vedtægter ændret: 03.10.2024
Kapitalforhøjelsen er besluttet den 03.10.2024.
kr. 69.081,00, indbetalt kontant, kurs 10.136,00.
Kapitalen udgør herefter kr. 383.261.451,00.
Vedtægter ændret: 23.09.2024
Bestyrelse:
Fratrådte:
Johannes Gerardus Joseph van de Winkel, den 31.07.2024.
Vedtægter ændret: 03.07.2024
Kapitalforhøjelsen er besluttet den 03.07.2024.
kr. 73.527,00, indbetalt kontant, kurs 10.136,00.
Kapitalen udgør herefter kr. 383.192.370,00.
Vedtægter ændret: 25.04.2024
Bestyrelse:
Fratrådte:
Jonas Wilhelm Agnblad, den 24.04.2024.
Tiltrådte:
Raj Rashmikant Shah, den 24.04.2024.
Vedtægter ændret: 08.04.2024
Kapitalforhøjelsen er besluttet den 08.04.2024.
kr. 74.956,00, indbetalt kontant, kurs 10.136,00.
Kapitalen udgør herefter kr. 383.118.843,00.
Bestyrelse:
Fratrådte:
Jesper Mailind, den 29.02.2024.
Valgt af medarbejderne i virksomheden:
Fratrådte:
Karin Attermann, den 01.03.2024.
Tiltrådte:
Henrik Bo Andersson, den 01.03.2024.
Suppleanter for valgt af medarbejderne i virksomheden:
Fratrådte:
Henrik Bo Andersson, den 01.03.2024.
Tiltrådte:
Thomas Christian Facius, den 01.03.2024.
Vedtægter ændret: 29.12.2023
Vedtægter ændret: 20.09.2023
Kapitalforhøjelsen er besluttet den 20.09.2023.
kr. 54.804.956,00, indbetalt ved konvertering af gæld, kurs 10.136,00. kr. 7.352.940,00, indbetalt kontant, kurs 10.136,00.
Kapitalen udgør herefter kr. 383.043.887,00.
Vedtægter ændret: 01.04.2023
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående fusion.
Virksomheden er fusioneret med CVR-nummer: 41600004 LEO Ventures A/S, der samtidigt er opløst.
Erhvervsstyrelsen har modtaget fusionsplan for den påtænkte fusion mellem CVR-nummer: 56759514 LEO PHARMA A/S (fortsættende), der tillige driver virksomhed under navnene LEO A/S, LEO INDUSTRIES A/S, LEO GROUP A/S, LEO INTERNATIONAL A/S, LEO PHARMACEUTICALS A/S, LEO INCUBATOR A/S, LØVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB, LEO PHARMACEUTICAL PRODUCTS LTD. A/S, LEO LABORATORIES LIMITED A/S, Intendis A/S og CVR-nummer: 41600004 LEO Ventures A/S (ophørende).
Der er endvidere modtaget erklæring fra vurderingsmændene om, at kreditorerne i CVR-nummer: 56759514 LEO PHARMA A/S og CVR-nummer: 41600004 LEO Ventures A/S må antages at være tilstrækkeligt sikrede efter fusionen.
Bestyrelse:
Valgt af medarbejderne i virksomheden:
Suppleanter for valgt af medarbejderne i virksomheden:
Fratrådte:
Thorsten Erik Ramsing, den 01.04.2023.
Tiltrådte:
Sara Melissa Plov Hoff, den 01.04.2023.
Bestyrelse:
Fratrådte:
Jesper Mailind, (næstformand), den 08.03.2023, Paul Olivier Marie Navarre, den 08.03.2023.
Tiltrådte:
Jesper Mailind, den 08.03.2023, Paul Olivier Marie Navarre, (næstformand), den 08.03.2023.
Vedtægter ændret: 31.12.2022
Kapitalforhøjelsen er besluttet den 31.12.2022.
kr. 154.878,00, indbetalt kontant, kurs 4.772,00.
Kapitalen udgør herefter kr. 320.885.991,00.
Vedtægter ændret: 29.12.2022
Vedtægter ændret: 30.09.2022
Kapitalforhøjelsen er besluttet den 30.09.2022.
kr. 179.097,00, indbetalt kontant, kurs 4.772,00.
Kapitalen udgør herefter kr. 320.731.113,00.
Direktion:
Fratrådte:
Anders Kronborg, den 15.09.2022.
Tiltrådte:
Philip Harald Eickhoff, den 15.09.2022.
Vedtægter ændret: 08.07.2022
Vedtægter ændret: 30.06.2022
Kapitalforhøjelsen er besluttet den 30.06.2022.
kr. 191.597,00, indbetalt kontant, kurs 4.772,00.
Kapitalen udgør herefter kr. 320.552.016,00.
Bestyrelse:
Valgt af medarbejderne i virksomheden:
Suppleanter for valgt af medarbejderne i virksomheden:
Fratrådte:
Louisa Channouf Jacobsen, den 01.07.2022.
Tiltrådte:
Klaus Legau, den 01.07.2022.
Vedtægter ændret: 31.03.2022
Kapitalforhøjelsen er besluttet den 31.03.2022.
kr. 215.348,00, indbetalt kontant, kurs 4.772,00.
Kapitalen udgør herefter kr. 320.360.419,00.
Direktion:
Fratrådte:
Anders Kronborg, (adm. dir), den 01.04.2022.
Tiltrådte:
Christophe Dominique Luc Charles Bourdon, (adm. dir), den 01.04.2022, Anders Kronborg, den 01.04.2022.
Vedtægter ændret: 16.03.2022
Bestyrelse:
Fratrådte:
Jesper Mailind, den 16.03.2022, Jane Maria Birgitta Stymne Göransson, den 16.03.2022, Anders Ekblom, (næstformand), den 16.03.2022.
Tiltrådte:
Jesper Mailind, (næstformand), den 16.03.2022.
Valgt af medarbejderne i virksomheden:
Fratrådte:
Karin Attermann, den 16.03.2022, Signe Maria Christensen, den 16.03.2022, Jannie Kogsbøll, den 16.03.2022, Franck Maréno, den 16.03.2022.
Tiltrådte:
Karin Attermann, den 16.03.2022, Signe Maria Christensen, den 16.03.2022, Jannie Kogsbøll, den 16.03.2022, Franck Maréno, den 16.03.2022.
Suppleanter for valgt af medarbejderne i virksomheden:
Fratrådte:
Sammy Islam Al-Moalem, den 16.03.2022, Henrik Bo Andersson, den 16.03.2022, Thomas Christian Facius, den 16.03.2022, Rifat Ramicevic, den 16.03.2022.
Tiltrådte:
Henrik Bo Andersson, den 16.03.2022, Louisa Channouf Jacobsen, den 16.03.2022, Kreesten Meldgaard Madsen, den 16.03.2022, Thorsten Erik Ramsing, den 16.03.2022.
Vedtægterne er yderligere ændret
Vedtægter ændret: 17.12.2021
Vedtægter ændret: 17.12.2021
Direktion:
Fratrådte:
Anders Kronborg, den 30.11.2021, Catherine Thérése Jeanne Mazzacco, (adm. dir), den 30.11.2021.
Tiltrådte:
Anders Kronborg, (adm. dir), den 30.11.2021.
Bestyrelse:
Fratrådte:
Jesper Mailind, (næstformand), den 01.08.2021, Anders Ekblom, (formand), den 01.08.2021.
Tiltrådte:
Jesper Brandgaard, (formand), den 01.08.2021, Jesper Mailind, den 01.08.2021, Anders Ekblom, (næstformand), den 01.08.2021.
Vedtægter ændret: 21.07.2021
Kapitalforhøjelsen er besluttet den 21.07.2021.
kr. 70.145.071,00, indbetalt kontant, kurs 4.771,75.
Kapitalen udgør herefter kr. 320.145.071,00.
Bestyrelse:
Tiltrådte:
Jonas Wilhelm Agnblad, den 21.07.2021.
Vedtægter ændret: 13.07.2021
Bestyrelse:
Fratrådte:
Jesper Mailind, den 06.05.2021, Anders Ekblom, (næstformand), den 06.05.2021, Olivier Bohuon, (formand), den 06.05.2021.
Tiltrådte:
Jesper Mailind, (næstformand), den 06.05.2021, Anders Ekblom, (formand), den 06.05.2021.
Bestyrelse:
Fratrådte:
Jesper Høiland, den 16.03.2021, CEO Cristina Patricia Lage, den 16.03.2021.
Tiltrådte:
Lars Green, den 16.03.2021.
Bestyrelse:
Valgt af medarbejderne i virksomheden:
Suppleanter for valgt af medarbejderne i virksomheden:
Fratrådte:
Fie Falck Larsen, den 11.02.2021.
Tiltrådte:
Thomas Christian Facius, den 11.02.2021.
Erhvervsstyrelsen har som kompetent myndighed i henhold til selskabslovens § 289, stk. 3, modtaget en attest fra den kompetente myndighed i Tyskland om, at alle handlinger og formaliteter der skal opfyldes i forhold til fusionen mellem CVR-nummer: 56759514, LEO PHARMA A/S, med hjemsted i Danmark og Intendis GmbH, med hjemsted i Tyskland, som er registreret i Tyskland med registreringsnummer: HRB 79750 B, er opfyldt for Intendis GmbH.
Erhvervsstyrelsen har som følge heraf registreret fusionen for LEO PHARMA A/S.
Vedtægter ændret: 28.08.2020
Nyt binavn: Intendis A/S
Bestyrelse:
Valgt af medarbejderne i virksomheden:
Suppleanter for valgt af medarbejderne i virksomheden:
Fratrådte:
Laurids Bonne Bjørnshauge, den 02.07.2020.
Tiltrådte:
Rifat Ramicevic, den 02.07.2020.
Erhvervsstyrelsen har modtaget fusionsplan for den påtænkte grænseoverskridende fusion mellem CVR-nummer: 56759514, LEO PHARMA A/S, med hjemsted i Danmark (fortsættende) og Intendis GmbH, med hjemsted i Tyskland, som er registreret i Tyskland med registreringsnummer HRB 79750 B (ophørende).
Der er endvidere modtaget erklæring fra vurderingsmændene om, at kreditorerne i selskaberne må antages at være tilstrækkeligt sikrede efter fusionen.
P-number 100665842355, 9999 Ukendt
P-number 1021469641Silkegade 8, 1113 København K
P-number 1003115132Mådevej 76, 6705 Esbjerg Ø
P-number 1003115120Industriparken 55, 2750 Ballerup
No other current company drawn.
No other current company drawn.
No other current company drawn.
No other current company drawn.
No other current company drawn.
No other current company drawn.
No other current company drawn.
No other current company drawn.
No other current company drawn.
No other current company drawn.